In patients with congenital or acquired defects in their host defenses, opportunistic fungal organisms tend to cause pneumonia.

The mainstay of therapy for fungal pneumonia routinely includes antifungal agents. The type of antifungal drug to be used must be tailored based on the particular pathogen that has been identified.